Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Catheter Precision (VTAK) Return on Capital Employed (2018 - 2025)

Catheter Precision (VTAK) has disclosed Return on Capital Employed for 8 consecutive years, with 0.71% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Capital Employed fell 26.0% to 0.71% in Q3 2025 year-over-year; TTM through Sep 2025 was 0.71%, a 26.0% decrease, with the full-year FY2024 number at 0.42%, up 325.0% from a year prior.
  • Return on Capital Employed was 0.71% for Q3 2025 at Catheter Precision, down from 0.69% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.45% in Q2 2024 to a low of 3.12% in Q1 2023.
  • A 5-year average of 1.44% and a median of 1.45% in 2021 define the central range for Return on Capital Employed.
  • Peak YoY movement for Return on Capital Employed: tumbled -162bps in 2023, then soared 259bps in 2024.
  • Catheter Precision's Return on Capital Employed stood at 1.57% in 2021, then crashed by -80bps to 2.82% in 2022, then increased by 5bps to 2.66% in 2023, then surged by 83bps to 0.45% in 2024, then plummeted by -58bps to 0.71% in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Return on Capital Employed are 0.71% (Q3 2025), 0.69% (Q2 2025), and 0.55% (Q1 2025).